Showing recent highlights
What's New
PubMed · December 15, 2026
Researchers found that a treatment called accelerated theta burst stimulation — which uses rapid bursts of magnetic pulses aimed at specific areas of the brain — did not work significantly better than a fake (inactive) version of the same treatment in people with depression that hadn't responded to other therapies. Even when the treatment was personalized using brain scans to target the right location or timing, it didn't lead to meaningful improvements in depression or low motivation (a common symptom where people lose interest in things they used to enjoy). This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · December 15, 2026
Researchers found that an antidepressant called vortioxetine may help improve both mood and certain thinking skills — like attention and how quickly the brain processes information — in older adults with depression. This matters because many common antidepressants don't seem to directly help with the memory and concentration problems that often come along with depression in older age, making everyday life harder. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that mindfulness exercises delivered through virtual reality (VR) headsets — where people are immersed in a calming digital environment — may help reduce feelings of depression and anxiety. The effect appeared especially strong in older adults, which is noteworthy because this group can sometimes face barriers to accessing traditional in-person mental health support. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 15, 2026
Researchers found that people with psychotic depression — a severe form of depression that can include losing touch with reality — were nearly twice as likely to show meaningful improvement when treated with a combination of an antidepressant and an antipsychotic medication together, compared to taking just one type of medication alone. This could matter because psychotic depression is often harder to treat than typical depression, and finding more effective approaches is an important step forward. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that taking omega-3 supplements (the kind found in fish oil) raises the levels of certain natural substances in the blood that help the body calm down inflammation — and this effect was especially strong in people who already had significant inflammation or other health burdens. This matters for people with depression because inflammation in the body is increasingly thought to play a role in how depression develops, and these findings suggest omega-3s may help fight depression partly by triggering the body's own inflammation-cooling system. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that talk-based therapies — especially a structured approach called cognitive-behavioral therapy, which helps people recognize and shift unhelpful thought patterns — significantly reduced feelings of depression in people with advanced kidney disease or those on dialysis, compared to routine medical care alone. Depression is very common in people living with kidney disease and can make their overall health worse, so finding that these non-medication approaches can help is an encouraging sign. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a brain stimulation technique called transcranial magnetic stimulation (TMS) — which uses magnetic pulses aimed at a specific part of the brain — may help people who have both depression and trouble sleeping. Across 7 studies involving 709 people, those who received TMS showed improvements in both sleep quality and depression symptoms, and the treatment appeared to be safe with few side effects. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that pregnant women with a history of depression who used an online mindfulness program called Mindful Mood Balance for Moms — on top of their regular care — were less likely to experience a return of depression compared to those who received regular care alone, both during pregnancy and in the six months after giving birth. Mindfulness is a practice that helps people stay focused on the present moment rather than getting caught up in worried or negative thoughts, and this program was designed specifically for pregnant and postpartum women. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that breast cancer survivors who took part in either an exercise program or an education program — where a doctor taught them about their health — saw lasting improvements in breast cancer-specific quality of life (how well they feel day-to-day in ways tied directly to their diagnosis) over 12 months. The education group felt better overall earlier on, at just 2 months in, compared to those who received standard care. However, the programs didn't show clear differences in anxiety or depression levels between the groups, so the full picture of how these programs help emotionally is still being worked out. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that a brain stimulation technique called tDCS — which uses a gentle electrical current applied to the scalp through small pads — may help reduce depression symptoms in people who hadn't fully responded to antidepressant medication. People who received the real stimulation scored noticeably better on a standard depression rating scale compared to those who received a fake (inactive) version of the treatment, though the results were complicated by the order in which people received each version. Researchers did not find a clear benefit for thinking or memory tasks in this study. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that people who also have personality difficulties — meaning deep-rooted patterns in how they think, feel, or relate to others that cause ongoing problems — tended to see less improvement in anxiety symptoms after psychological treatments like cognitive-behavioral therapy (CBT), a structured talking therapy that helps people change unhelpful thought patterns. The more severe the personality difficulties, the smaller the benefit for anxiety. Social functioning, meaning how well people were able to get on with daily life and relationships, improved for everyone regardless of personality difficulties. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
Researchers found that talk therapy sessions focused on changing unhelpful thought patterns — delivered not by psychiatrists or psychologists, but by trained nurses, midwives, and other non-specialist helpers — helped reduce depression and anxiety symptoms in people during pregnancy or after giving birth. The effect was meaningful right after the sessions ended, and there were even some signs the benefits lasted up to a year later. This matters because it suggests that mental health support during this vulnerable time doesn't always have to come from a specialist, which could make care more widely available. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · November 1, 2026
A study found that a short course of mifepristone — a drug that blocks certain stress hormones in the body — did not reduce depression symptoms any better than a sugar pill in adults who had experienced childhood trauma and were living with depression. Both groups did improve over six weeks, but the medication didn't appear to be the reason. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that PARO — a soft, seal-shaped therapeutic robot designed to provide comfort and companionship — helped reduce agitation, anxiety, and depression in people with dementia living in Australian healthcare settings. Across six studies involving over 1,400 participants, interacting with the robot appeared to ease some of the difficult emotional and behavioral symptoms that often come with Alzheimer's disease and other forms of dementia, which can be hard to manage and deeply affect quality of life. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that in people with depression, tiny energy-producing structures inside cells — called mitochondria — may not be working properly, and this breakdown appears to trigger inflammation in the brain, which in turn makes the mitochondria work even worse, creating a harmful cycle. This matters because it suggests that treatments aimed at fixing this energy-and-inflammation loop — including some already-used medications and newer approaches — might open up new ways to help people whose depression hasn't responded well to current options. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that people who experience something called Cognitive Disengagement Syndrome — a pattern of symptoms like mental fogginess, daydreaming, and feeling mentally 'slowed down' — were significantly more likely to also have depression or anxiety, with over a third meeting the threshold for a clinical diagnosis. The link to depression was especially strong, and importantly, this connection held up even when researchers accounted for attention difficulties, suggesting it's a separate factor worth paying attention to. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that not all antidepressants affect the body the same way when it comes to insulin resistance — a condition where the body struggles to use blood sugar properly. Some older antidepressants (like nortriptyline and amitriptyline) appeared to make insulin resistance worse, while others, such as bupropion and agomelatine, seemed to have little negative effect and might even help. For someone with depression who is also concerned about blood sugar, this could matter — but this is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
A study found that a type of sleep-targeting medication called an orexin receptor antagonist — which works by calming the brain's "wake-up" signals — may help reduce depression symptoms in people who haven't responded well to common antidepressants like SSRIs or SNRIs, and who also struggle with ongoing sleep problems. Researchers looked at multiple studies combined and found modest but meaningful improvements in depression scores when this medication was added to a person's existing treatment. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that hands-on physical treatments — such as massage, chiropractic care, and similar touch-based therapies — may help reduce symptoms of depression when used alongside standard treatments like therapy or medication. This could matter for people with depression because it suggests there may be additional ways to support their mental health beyond traditional approaches. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed (Open Access Guidelines) · November 1, 2026
Researchers found that people who tend toward perfectionism — setting extremely high standards for themselves and being very self-critical when they fall short — may not respond as well to mental health treatment, including treatment for depression. In studies involving people with depression, higher levels of perfectionism at the start of treatment were linked to worse outcomes, suggesting that this personality trait might get in the way of recovery. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · November 1, 2026
Researchers found that people with type 2 diabetes and depression who practiced Tai Chi or Baduanjin — traditional Chinese slow, flowing movement exercises done regularly over several weeks — showed meaningful improvements in both their mood and their blood sugar level (A1C), compared to those who didn't practice these exercises. Baduanjin involves a series of eight gentle, standing movements often described as 'Eight Pieces of Brocade,' while Tai Chi uses slow, continuous motions that flow from one pose to the next. The researchers noted that most of the studies reviewed were small and conducted in China, so more research is needed to know how well these findings apply to people in other settings.
What's New
PubMed · November 1, 2026
Researchers found that teenagers with depression had noticeably different fat molecule (lipid) patterns in their blood compared to teenagers without depression — and that some of those patterns shifted after eight weeks of treatment with fluoxetine, a common antidepressant. This matters because finding measurable differences in the blood could one day help doctors identify depression more objectively, rather than relying on symptoms alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 26, 2026
Researchers found that certain crisis support services — including brief structured approaches and programs that involve the whole family — may help children and adolescents going through severe depression or thoughts of self-harm by reducing those thoughts, lowering the chances of a hospital stay, and improving how families communicate and support each other. Rather than being admitted to a hospital, young people in these programs received intensive help in their everyday environment, which appeared to make a real difference. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 23, 2026
A study found that when antidepressants alone aren't working well enough for people with depression, adding a second type of medication — known as an atypical antipsychotic — may help improve symptoms, and experts reviewed the evidence to better understand which options tend to work best and have the fewest side effects. A group of five psychiatry experts compared findings from two large analyses of existing research to help doctors make more informed choices when deciding together with their patients which medication combination might be the right fit. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 23, 2026
Researchers found that older adults who used an AI-powered virtual companion — essentially a conversational chatbot designed to offer emotional support — showed improvements in feelings of loneliness and depressive symptoms compared to those who just took part in regular social activities. The idea is that for older adults who are cut off from regular social contact, having a responsive, personalized digital companion might help fill some of that emotional gap. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 21, 2026
Researchers found that women experiencing depression during pregnancy or shortly after giving birth were more likely to *feel* forgetful and mentally foggy — but when tested objectively, the results were mixed, meaning the mental struggles they reported didn't always show up clearly on memory or attention tests. One consistent pattern was that depression seemed connected to difficulties with autobiographical memory, which is the ability to recall personal life experiences. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 21, 2026
Researchers found that semaglutide — a diabetes medication like Ozempic — may affect how people with depression make decisions, specifically the balance between sticking with a known good option and trying something new to gather information. People taking semaglutide showed changes in this decision-making pattern compared to those taking a placebo, and these effects appeared to be separate from any weight loss the medication caused, which is interesting because it suggests the drug might be influencing the brain more directly. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · October 19, 2026
A study found that when therapists were shown summaries of their patients' real text messages before sessions — with patients' permission — those patients showed greater improvements in depression symptoms compared to people who received standard therapy without that extra information. The idea is that everyday texts can reveal how someone is actually feeling between appointments, giving therapists a fuller, more honest picture of their patient's life. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · October 18, 2026
Scientists found that there are three specific pathways in the brain that, when properly reached during deep brain stimulation — a treatment where small electrical impulses are delivered to targeted areas of the brain — are linked to lasting relief from severe depression that hasn't responded to other treatments. They also noticed that people who didn't improve shared something in common: a key brain connection wasn't being stimulated enough, often because the electrode was placed even slightly off-target. This suggests that tiny, precise differences in where the device is positioned in the brain could have a big impact on whether someone feels better long-term.
What's New
PubMed · October 16, 2026
Researchers found that moxibustion — a traditional Chinese medicine technique that uses heat from burning herbs near the skin — may help reduce symptoms of depression, either on its own or alongside other treatments. Across 15 studies involving over 1,500 patients, its effectiveness appeared comparable to antidepressant medications, which is a notable finding for people exploring different approaches to managing depression. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.